BACKGROUND: Usher syndrome type II (USH2) is an autosomal recessive disorder characterised by retinitis pigmentosa (RP) and mild to moderate sensorineural hearing loss. Mutations in the USH2A gene are the most common cause of USH2 and are also a cause of some forms of RP without hearing loss (ie, non-syndromic RP). The USH2A gene was initially identified as a transcript comprised of 21 exons but subsequently a longer isoform containing 72 exons was identified. METHODS: The 51 exons unique to the long isoform of USH2A were screened for mutations among a core set of 108 patients diagnosed with USH2 and 80 patients with non-syndromic RP who were all included in a previously reported screen of the short isoform of USH2A. For several exons, additional patients were screened. RESULTS: In total, 35 deleterious mutations were identified including 17 nonsense mutations, 9 frameshift mutations, 5 splice-site mutations, and 4 small in-frame deletions or insertions. Twenty-seven mutations were novel. In addition, 65 rare missense changes were identified. A method of classifying the deleterious effect of the missense changes was developed using the summed results of four different mutation assessment algorithms, SIFT, pMUT, PolyPhen, and AGVGD. This system classified 8 of the 65 changes as 'likely deleterious' and 9 as 'possibly deleterious'. CONCLUSION: At least one mutation was identified in 57-63% of USH2 cases and 19-23% of cases of non-syndromic recessive RP (calculated without and including probable/possible deleterious changes) thus supporting that USH2A is the most common known cause of RP in the USA.
BACKGROUND:Usher syndrome type II (USH2) is an autosomal recessive disorder characterised by retinitis pigmentosa (RP) and mild to moderate sensorineural hearing loss. Mutations in the USH2A gene are the most common cause of USH2 and are also a cause of some forms of RP without hearing loss (ie, non-syndromic RP). The USH2A gene was initially identified as a transcript comprised of 21 exons but subsequently a longer isoform containing 72 exons was identified. METHODS: The 51 exons unique to the long isoform of USH2A were screened for mutations among a core set of 108 patients diagnosed with USH2 and 80 patients with non-syndromic RP who were all included in a previously reported screen of the short isoform of USH2A. For several exons, additional patients were screened. RESULTS: In total, 35 deleterious mutations were identified including 17 nonsense mutations, 9 frameshift mutations, 5 splice-site mutations, and 4 small in-frame deletions or insertions. Twenty-seven mutations were novel. In addition, 65 rare missense changes were identified. A method of classifying the deleterious effect of the missense changes was developed using the summed results of four different mutation assessment algorithms, SIFT, pMUT, PolyPhen, and AGVGD. This system classified 8 of the 65 changes as 'likely deleterious' and 9 as 'possibly deleterious'. CONCLUSION: At least one mutation was identified in 57-63% of USH2 cases and 19-23% of cases of non-syndromic recessive RP (calculated without and including probable/possible deleterious changes) thus supporting that USH2A is the most common known cause of RP in the USA.
Authors: J M Bork; L M Peters; S Riazuddin; S L Bernstein; Z M Ahmed; S L Ness; R Polomeno; A Ramesh; M Schloss; C R Srisailpathy; S Wayne; S Bellman; D Desmukh; Z Ahmed; S N Khan; V M Kaloustian; X C Li; A Lalwani; S Riazuddin; M Bitner-Glindzicz; W E Nance; X Z Liu; G Wistow; R J Smith; A J Griffith; E R Wilcox; T B Friedman; R J Morell Journal: Am J Hum Genet Date: 2000-11-21 Impact factor: 11.025
Authors: B Dreyer; L Tranebjaerg; V Brox; T Rosenberg; C Möller; M Beneyto; M D Weston; W J Kimberling; C W Cremers; X Z Liu; O Nilssen Journal: Am J Hum Genet Date: 2001-06-08 Impact factor: 11.025
Authors: H Bolz; B von Brederlow; A Ramírez; E C Bryda; K Kutsche; H G Nothwang; M Seeliger; M del C-Salcedó Cabrera; M C Vila; O P Molina; A Gal; C Kubisch Journal: Nat Genet Date: 2001-01 Impact factor: 38.330
Authors: Z M Ahmed; S Riazuddin; S L Bernstein; Z Ahmed; S Khan; A J Griffith; R J Morell; T B Friedman; S Riazuddin; E R Wilcox Journal: Am J Hum Genet Date: 2001-06-07 Impact factor: 11.025
Authors: K N Alagramam; H Yuan; M H Kuehn; C L Murcia; S Wayne; C R Srisailpathy; R B Lowry; R Knaus; L Van Laer; F P Bernier; S Schwartz; C Lee; C C Morton; R F Mullins; A Ramesh; G Van Camp; G S Hageman; R P Woychik; R J Smith; G S Hagemen Journal: Hum Mol Genet Date: 2001-08-01 Impact factor: 6.150
Authors: M D Weston; J D Eudy; S Fujita; S Yao; S Usami; C Cremers; J Greenberg; R Ramesar; A Martini; C Moller; R J Smith; J Sumegi; W J Kimberling; J Greenburg Journal: Am J Hum Genet Date: 2000-03-22 Impact factor: 11.025
Authors: T Joensuu; R Hämäläinen; B Yuan; C Johnson; S Tegelberg; P Gasparini; L Zelante; U Pirvola; L Pakarinen; A E Lehesjoki; A de la Chapelle; E M Sankila Journal: Am J Hum Genet Date: 2001-08-27 Impact factor: 11.025
Authors: Gema Garcia-Garcia; Maria J Aparisi; Teresa Jaijo; Regina Rodrigo; Ana M Leon; Almudena Avila-Fernandez; Fiona Blanco-Kelly; Sara Bernal; Rafael Navarro; Manuel Diaz-Llopis; Montserrat Baiget; Carmen Ayuso; Jose M Millan; Elena Aller Journal: Orphanet J Rare Dis Date: 2011-10-17 Impact factor: 4.123
Authors: B Maranhao; P Biswas; J L Duncan; K E Branham; G A Silva; M A Naeem; S N Khan; S Riazuddin; J F Hejtmancik; J R Heckenlively; S A Riazuddin; P L Lee; R Ayyagari Journal: Genomics Date: 2014-03-03 Impact factor: 5.736
Authors: Jin Song; Nizar Smaoui; Radha Ayyagari; David Stiles; Sonia Benhamed; Ian M MacDonald; Stephen P Daiger; Santa J Tumminia; Fielding Hejtmancik; Xinjing Wang Journal: Invest Ophthalmol Vis Sci Date: 2011-11-25 Impact factor: 4.799
Authors: Kari Branham; Mohammad Othman; Matthew Brumm; Athanasios J Karoukis; Pelin Atmaca-Sonmez; Beverly M Yashar; Sharon B Schwartz; Niamh B Stover; Karmen Trzupek; Dianna Wheaton; Barbara Jennings; Maria Laura Ciccarelli; K Thiran Jayasundera; Richard A Lewis; David Birch; Jean Bennett; Paul A Sieving; Sten Andreasson; Jacque L Duncan; Gerald A Fishman; Alessandro Iannaccone; Richard G Weleber; Samuel G Jacobson; John R Heckenlively; Anand Swaroop Journal: Invest Ophthalmol Vis Sci Date: 2012-12-13 Impact factor: 4.799
Authors: Kevin T Booth; Hela Azaiez; Kimia Kahrizi; Allen C Simpson; William T A Tollefson; Christina M Sloan; Nicole C Meyer; Mojgan Babanejad; Fariba Ardalani; Sanaz Arzhangi; Michael J Schnieders; Hossein Najmabadi; Richard J H Smith Journal: Am J Med Genet A Date: 2015-09-29 Impact factor: 2.802
Authors: Margo Dona; Ralph Slijkerman; Kimberly Lerner; Sanne Broekman; Jeremy Wegner; Taylor Howat; Theo Peters; Lisette Hetterschijt; Nanda Boon; Erik de Vrieze; Nasrin Sorusch; Uwe Wolfrum; Hannie Kremer; Stephan Neuhauss; Jingjing Zang; Maarten Kamermans; Monte Westerfield; Jennifer Phillips; Erwin van Wijk Journal: Exp Eye Res Date: 2018-05-16 Impact factor: 3.467